These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
463 related articles for article (PubMed ID: 12460908)
1. A mycobacterial iron chelator, desferri-exochelin, induces hypoxia-inducible factors 1 and 2, NIP3, and vascular endothelial growth factor in cancer cell lines. Chong TW; Horwitz LD; Moore JW; Sowter HM; Harris AL Cancer Res; 2002 Dec; 62(23):6924-7. PubMed ID: 12460908 [TBL] [Abstract][Full Text] [Related]
2. Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma. Sivridis E; Giatromanolaki A; Gatter KC; Harris AL; Koukourakis MI; Cancer; 2002 Sep; 95(5):1055-63. PubMed ID: 12209691 [TBL] [Abstract][Full Text] [Related]
3. Relation of vascular endothelial growth factor production to expression and regulation of hypoxia-inducible factor-1 alpha and hypoxia-inducible factor-2 alpha in human bladder tumors and cell lines. Jones A; Fujiyama C; Blanche C; Moore JW; Fuggle S; Cranston D; Bicknell R; Harris AL Clin Cancer Res; 2001 May; 7(5):1263-72. PubMed ID: 11350893 [TBL] [Abstract][Full Text] [Related]
4. Hypoxia-induced changes in the expression of VEGF, HIF-1 alpha and cell cycle-related molecules in ovarian cancer cells. Horiuchi A; Imai T; Shimizu M; Oka K; Wang C; Nikaido T; Konishi I Anticancer Res; 2002; 22(5):2697-702. PubMed ID: 12529984 [TBL] [Abstract][Full Text] [Related]
5. V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression. Jiang BH; Agani F; Passaniti A; Semenza GL Cancer Res; 1997 Dec; 57(23):5328-35. PubMed ID: 9393757 [TBL] [Abstract][Full Text] [Related]
6. Up-regulation of hypoxia-inducible factor 2alpha in renal cell carcinoma associated with loss of Tsc-2 tumor suppressor gene. Liu MY; Poellinger L; Walker CL Cancer Res; 2003 May; 63(10):2675-80. PubMed ID: 12750296 [TBL] [Abstract][Full Text] [Related]
7. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway. Blancher C; Moore JW; Robertson N; Harris AL Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776 [TBL] [Abstract][Full Text] [Related]
8. The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis. Welsh SJ; Bellamy WT; Briehl MM; Powis G Cancer Res; 2002 Sep; 62(17):5089-95. PubMed ID: 12208766 [TBL] [Abstract][Full Text] [Related]
9. Relationship of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression to vascular endothelial growth factor induction and hypoxia survival in human breast cancer cell lines. Blancher C; Moore JW; Talks KL; Houlbrook S; Harris AL Cancer Res; 2000 Dec; 60(24):7106-13. PubMed ID: 11156418 [TBL] [Abstract][Full Text] [Related]
10. HIF-1alpha-mediated up-regulation of vascular endothelial growth factor, independent of basic fibroblast growth factor, is important in the switch to the angiogenic phenotype during early tumorigenesis. Fang J; Yan L; Shing Y; Moses MA Cancer Res; 2001 Aug; 61(15):5731-5. PubMed ID: 11479208 [TBL] [Abstract][Full Text] [Related]
12. HIF-1-dependent regulation of hypoxic induction of the cell death factors BNIP3 and NIX in human tumors. Sowter HM; Ratcliffe PJ; Watson P; Greenberg AH; Harris AL Cancer Res; 2001 Sep; 61(18):6669-73. PubMed ID: 11559532 [TBL] [Abstract][Full Text] [Related]
13. Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma. Ferrario A; von Tiehl KF; Rucker N; Schwarz MA; Gill PS; Gomer CJ Cancer Res; 2000 Aug; 60(15):4066-9. PubMed ID: 10945611 [TBL] [Abstract][Full Text] [Related]
14. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Carmeliet P; Dor Y; Herbert JM; Fukumura D; Brusselmans K; Dewerchin M; Neeman M; Bono F; Abramovitch R; Maxwell P; Koch CJ; Ratcliffe P; Moons L; Jain RK; Collen D; Keshert E Nature; 1998 Jul; 394(6692):485-90. PubMed ID: 9697772 [TBL] [Abstract][Full Text] [Related]
15. Stabilization of vascular endothelial growth factor mRNA by hypoxia-inducible factor 1. Liu LX; Lu H; Luo Y; Date T; Belanger AJ; Vincent KA; Akita GY; Goldberg M; Cheng SH; Gregory RJ; Jiang C Biochem Biophys Res Commun; 2002 Mar; 291(4):908-14. PubMed ID: 11866451 [TBL] [Abstract][Full Text] [Related]
16. Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway. Rapisarda A; Uranchimeg B; Scudiero DA; Selby M; Sausville EA; Shoemaker RH; Melillo G Cancer Res; 2002 Aug; 62(15):4316-24. PubMed ID: 12154035 [TBL] [Abstract][Full Text] [Related]
17. Capsaicin regulates vascular endothelial cell growth factor expression by modulation of hypoxia inducing factor-1alpha in human malignant melanoma cells. Patel PS; Yang S; Li A; Varney ML; Singh RK J Cancer Res Clin Oncol; 2002 Sep; 128(9):461-8. PubMed ID: 12242509 [TBL] [Abstract][Full Text] [Related]
18. A hypoxia-driven vascular endothelial growth factor/Flt1 autocrine loop interacts with hypoxia-inducible factor-1alpha through mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 pathway in neuroblastoma. Das B; Yeger H; Tsuchida R; Torkin R; Gee MF; Thorner PS; Shibuya M; Malkin D; Baruchel S Cancer Res; 2005 Aug; 65(16):7267-75. PubMed ID: 16103078 [TBL] [Abstract][Full Text] [Related]
19. Angiogenesis and prostate cancer: identification of a molecular progression switch. Huss WJ; Hanrahan CF; Barrios RJ; Simons JW; Greenberg NM Cancer Res; 2001 Mar; 61(6):2736-43. PubMed ID: 11289156 [TBL] [Abstract][Full Text] [Related]